Qinwei Yu

Wuhan Red Cross Hospital

H指数:14

被引数:634

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

RORα as a Context-Dependent Transcriptional Stabilizer in the Nervous System

RORα作为神经系统中的情境依赖性转录稳定因子

Neuroscience and Biobehavioral Reviews

IF7.9

2026-09-120

OAAI

Botulinum Toxin Therapy for Neurological Disorders: Serendipitous Benefits on Sleep Quality and Underlying Mechanisms

肉毒毒素疗法在神经系统疾病中的应用：对睡眠质量的偶然益处及其潜在机制

Sleep Medicine Reviews

IF9.7

2025-10-010

PRE

Obeticholic acid exacerbates liver injury through hepatocyte-mediated release of HMGB1 by inducing lysosomal membrane permeabilization in cholestasis

奥贝胆酸通过诱导溶酶体膜通透性增加，加剧肝细胞介导的高迁移率族蛋白1（HMGB1）释放，从而在胆汁淤积中加重肝脏损伤。

Chemico-Biological Interactions

IF5.4

2025-09-150

PRE

Restless legs syndrome in Parkinson’s disease: epidemiology, pathogenetic overlaps, and clinical management

帕金森病中的不宁腿综合征：流行病学、发病机制重叠及临床管理

Journal of Neurology

IF4.6

2025-08-110

Fenofibrate promotes erucic acid metabolism by peroxisome enzyme EHHADH activation alleviating high-fat diet–induced steatotic liver disease

非诺贝特通过过氧化物酶体酶EHHADH的激活促进芥酸代谢，从而缓解高脂饮食诱导的脂肪肝疾病。

Molecular Pharmacology

IF3

2025-05-160

PRE

A combined detection of α-synuclein-related proteins enables accurate diagnosis of Parkinson's disease using a transistor biosensor

SENSORS AND ACTUATORS B-CHEMICAL

IF7.7

2025-03-010

PRE

Obeticholic acid aggravates liver fibrosis by activating hepatic farnesoid X receptor-induced apoptosis in cholestatic mice

奥贝胆酸通过激活肝法尼醇X受体诱导的凋亡，加剧胆汁淤积小鼠的肝纤维化

CHEMICO-BIOLOGICAL INTERACTIONS

IF5.4

2025-01-010

PRE

NR1H4 ameliorates Parkinson's disease via inhibiting astrocyte activation and neuroinflammation in a CEBP(3/NF-κB dependent manner

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2024-12-010

OAAI

Silybin Meglumine Mitigates CCl4-Induced Liver Fibrosis and Bile Acid Metabolism Alterations

METABOLITES

IF3.7

2024-10-171

OAAI

Diarylpropionitrile-stimulated ERβ nuclear accumulation promotes MyoD-induced muscle regeneration in mdx mice by interacting with FOXO3A

PHARMACOLOGICAL RESEARCH

IF10.5

2024-10-010

OAAI

Novel Dual PPAR δ/γ Partial Agonist Induces Hepatic Lipid Accumulation through Direct Binding and Inhibition of AKT1 Phosphorylation, Mediating CD36 Upregulation

CHEMICAL RESEARCH IN TOXICOLOGY

IF3.8

2024-09-050

PRE

Medical education challenges in Mainland China: An analysis of the application of problem-based learning

中国大陆医学教育面临的挑战: 基于问题的学习应用分析

MEDICAL TEACHER

IF4.4

2024-07-291

Proteasome activity inhibition mediates endoplasmic reticulum stress-apoptosis in triptolide/lipopolysaccharide-induced hepatotoxicity

CELL BIOLOGY AND TOXICOLOGY

IF5.9

2024-07-290

OAAI

Tamoxifen upregulates the peroxisomal β-oxidation enzyme Enoyl CoA hydratase and 3-hydroxyacyl CoA hydratase ameliorating hepatic lipid accumulation in mice

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

IF2.8

2024-07-011

PRE

Oncofetal SNRPE promotes HCC tumorigenesis by regulating the FGFR4 expression through alternative splicing

BRITISH JOURNAL OF CANCER

IF6.8

2024-05-254

PRE

Group 1 innate lymphoid cell activation via recognition of NKG2D and liver resident macrophage MULT-1: Collaborated roles in triptolide induced hepatic immunotoxicity in mice

ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY

IF6.1

2024-03-011

OAAI

CHIR-98014, a GSK 3β Inhibitor, Protects Against Triptolide/Lipopolysaccharide-Induced Hepatotoxicity by Mitochondria-Dependent Apoptosis Inhibition

CHEMICAL RESEARCH IN TOXICOLOGY

IF3.8

2024-01-291

PRE

Obeticholic acid protects against lithocholic acid-induced exogenous cell apoptosis during cholestatic liver injury

LIFE SCIENCES

IF5.1

2024-01-017

PRE

Obstructive sleep apnea in Parkinson's disease: A prevalent, clinically relevant and treatable feature

PARKINSONISM & RELATED DISORDERS

IF3.4

2023-10-0110

OAAI

Total glucosides of Rhizoma Smilacis Glabrae: a therapeutic approach for psoriasis by regulating Th17/Treg balance

土茯苓总苷调节Th17/Treg平衡治疗银屑病

CHINESE JOURNAL OF NATURAL MEDICINES

IF4.9

2023-08-018

PRE

Qinwei Yu

个人简介

教育背景

工作经历

荣誉奖项

研究方向